Serum exosomal tsRNA biomarkers: A novel strategy for identifying lupus nephritis

References

[1] Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update omicron the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80(1):14-25.

[2] Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers. 2020;6(1):7.

[3] Fanouriakis A, Kostopoulou M, Cheema K, et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis. 2020;79(6):713-723.

[4] Shi J, Zhang Y, Tan D, et al. PANDORA-seq expands the repertoire of regulatory small RNAs by overcoming RNA modifications. Nat Cell Biol. 2021;23(4):424-436.

[5] Zhang X, Yang P, Khan A, et al. Serum tsRNA as a novel molecular diagnostic biomarker for lupus nephritis. Clin Transl Med. 2022;12(5):e830.

[6] Jin F, Yang L, Wang W, et al. A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer. Mol Cancer. 2021;20(1):95.

[7] Yang P, Zhang X, Chen S, et al. A novel serum tsRNA for diagnosis and prediction of nephritis in SLE. Front Immunol. 2021;12:735105.

[8] Kita S, Shimomura I. Extracellular vesicles as an endocrine mechanism connecting distant cells. Mol Cells. 2022;45(11):771-780.

[9] Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.

[10] Shoenfeld Y, Giacomelli R, Azrielant S, Berardicurti O, Reynolds JA, Bruce IN. Vitamin D and systemic lupus erythematosus—the hype and the hope. Autoimmun Rev. 2018;17(1):19-23.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.